ROCKVILLE, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central...
1 Cash-Heavy Stock on Our Buy List and 2 We Brush Off
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
2 Cash-Producing Stocks to Consider Right Now and 1 Facing Headwinds
3 Unprofitable Stocks We Steer Clear Of
3 Low-Volatility Stocks We’re Skeptical Of
3 of Wall Street’s Favorite Stocks That Concern Us
1 Cash-Heavy Stock for Long-Term Investors and 2 We Turn Down
3 Stocks Under $50 That Concern Us
3 Unprofitable Stocks We Find Risky